CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 672 enrolled
Drug / intervention
InfraScanner 2000™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04505293
NCT04505293N/ACompleted

Assessment of Accuracy, Precision, and Feasibility of a Handheld Near-Infrared Light Device (InfraScanner 2000™) in Detecting Subdural and Epidural Hematomas in Patients Admitted to Duke University Hospital and Mbarara Regional Referral Hospital: A Pilot Study

Duke University·interventional·Posted Aug 10, 2020·Updated Mar 19, 2024

In Brief

A clinical study evaluating InfraScanner 2000™ for Head Trauma and 15 related conditions. Completed, enrolled 672 participants across 2 sites in 2 countries.

Detailed Summary

The goal of this study is to determine the sensitivity, specificity, and positive and negative predictive values of the a portable near-infrared-based device (portable NIR-based device), the InfraScanner 2000™, to detect intracranial hematomas (epidural hematomas (EDH) and/or subdural hematomas (SDH)) in patients hospitalized at Mbarara Regional Referral Hospital (MRRH) who have sustained or who are suspected to have sustained head trauma.

Study Details

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 10, 2020
Enrollment StartOct 5, 2021
Primary CompletionJun 29, 2022
Study CompletionAug 5, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.9 years ago

Interventions

InfraScanner 2000™device

The Infrascanner is a portable screening device that uses Near-Infrared (NIR) technology to screen patients for intracranial bleeding, identifying those who would most benefit from immediate referral to a CT scan and neurosurgical intervention.